Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia

Journal of Clinical Oncology

Volumn 20, Issue 13, 2002, Pages 2959-2964

  Leung, Wing ^a   Rose, Susan R ^a   Zhou, Yinmei ^a   Hancock, Michael L ^a   Burstein, Stephen ^a   Schriock, Elizabeth A ^a   Lustig, Robert ^a   Danish, Robert K ^a   Evans, William E ^a   Hudson, Melissa M ^a   Pui, Ching Hon ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER RISK; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SECOND CANCER; SIDE EFFECT;

ADOLESCENT; BODY HEIGHT; CHILD; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; NEOPLASMS, SECOND PRIMARY; RECURRENCE; RETROSPECTIVE STUDIES; TENNESSEE;

EID: 0036645443     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.09.142     Document Type: Article

References (34)

1. Acute lymphoblastic leukemia
2. Height of children successfully treated for acute lymphoblastic leukemia: A report from the Late Effects Study Committee of Childrens Cancer Study Group
3. Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia
4. Growth in children treated for acute lymphoblastic leukaemia
5. Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia
6. Factors contributing to the impairment of growth in children with acute lymphoblastic leukemia
7. Final height after treatment for childhood acute lymphoblastic leukemia: Comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation
8. Final attained height in patients successfully treated for childhood acute lymphoblastic leukemia
9. Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia
10. Adult height after growth hormone (GH) treatment for GH deficiency due to cranial irradiation
11. Failure of late intensification therapy to improve a poor result in childhood lymphoblastic leukemia
12. Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: Long-term results of St Jude total therapy study X
13. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy
14. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia
15. The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency
16. Prediction of adult height from height and bone age in childhood: A new system of equations (TW Mark II) based on a sample including very tall and very short children
17. Late effects of treatment in survivors of childhood acute myeloid leukemia
18. Second malignancy after treatment of childhood non-Hodgkin lymphoma
19. A class of K-sample tests for comparing the cumulative incidence of a competing risk
20. Analysis of time to death after transplantation when transplants are only given to patients in remission
21. Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH: The Genentech Growth Study Group
22. Final height of short normal children treated with growth hormone
23. Effect of growth hormone treatment on the adult height of children with chronic renal failure: German Study Group for Growth Hormone Treatment in Chronic Renal Failure
24. Possible effects of growth hormone on development of acute lymphoblastic leukemia
25. Leukemia in patients treated with growth hormone
26. Leukemia in patients treated with growth hormone
27. Leukemia in patients treated with growth hormone
28. Leukemia and growth hormone
29. Risk of leukemia after treatment with pituitary growth hormone
30. Risk of leukemia in children treated with human growth hormone: Review and reanalysis
31. Recent status in the occurrence of leukemia in growth hormone-treated patients in Japan: GH Treatment Study Committee of the Foundation for Growth Science, Japan
32. Second neoplasms after acute lymphoblastic leukemia in childhood
33. Growth hormone therapy in adults and children